MEXILETINE (Namuscla®)

Clinical Indication

Symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders


Not yet reviewd

Date of classification

January 2020

Review date

January 2020


Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.